A Brief Review on Isotretinoin

Authors

  • S. Santhoshi Reddy Student, Joginpally BR Pharmacy College, Hyderabad, India
  • M. Meena Kumari Department of Pharmacology, Joginpally BR Pharmacy College, Hyderabad, India
  • J. V. C. Sharma Department of Pharmacognosy, Joginpally BR Pharmacy College, Hyderabad, India
  • A. V. S. S. S. Gupta Department of Pharmacology, Joginpally BR Pharmacy College, Hyderabad, India

Keywords:

fetal anomalies, isotretinoin, nodular acne

Abstract

The aim of this review article is to bring awareness about the isotretinoin [B-cis-retinoic acid] which is the teratogenic medication used in the treatment of nodular acne and other skin related problems, this article focuses on the composition, mechanism of action, abnormalities, adverse effects, contradictions and its teratogenic effect. This review article concludes that isotrtinoin should not be taken or prescribed to avoid the reproductive toxicity or fetal anomalies, because this shows its action on cell proliferation and apoptosis.

Downloads

Download data is not yet available.

Downloads

Published

19-12-2021

Issue

Vol. 4 No. 12 (2021)

Section

Articles

License

Copyright (c) 2021 S. Santhoshi Reddy, M. Meena Kumari, J. V. C. Sharma, A. V. S. S. S. Gupta

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
S. S. Reddy, M. M. Kumari, J. V. C. Sharma, and A. V. S. S. S. Gupta, “A Brief Review on Isotretinoin”, IJRESM, vol. 4, no. 12, pp. 66–68, Dec. 2021, Accessed: Oct. 30, 2024. [Online]. Available: https://journal.ijresm.com/index.php/ijresm/article/view/1598

Most read articles by the same author(s)